Geron Corporation (NASDAQ: GERN) is 9.50% higher on its value in year-to-date trading and has touched a low of $1.01 and a high of $3.84 in the current 52-week trading range. The question becomes, what are the chances the stock will continue to grow shareholders’ wealth in the market. Here’s what analysts think will happen to its price in the coming time. The GERN stock was last observed hovering at around $2.62 in the last trading session, with the day’s gains setting it 0.03%.
Currently trading at $2.65, the stock is -3.64% and -10.55% below its SMA20 and SMA50 respectively. However, with a daily trading volume of 3.97 million and changing 1.15% at the moment leaves the stock 14.28% off its SMA200. GERN registered 154.81% gain for a year compared to 6-month loss of -7.34%.
From Robots to Self-Driving Cars: 5 AI Stocks to Consider for Your Portfolio
The artificial intelligence (AI) revolution is already here and it's about to change everything we know about everything. With the global market for AI projected to grow from $137 billion in 2022 to over $1.81 trillion by 2030, there's never been a better time to invest in this burgeoning industry. That's why we've compiled a list of the Top 5 AI Stocks to Buy for 2023. These companies are at the forefront of the AI revolution, and have the potential to deliver huge returns to investors like you.
Get our free report, "Top 5 AI Stocks to Buy for 2023".
Sponsored
The stock witnessed a -0.38% gain in the last 1 month and extending the period to 3 months gives it a 12.29%, and is -1.12% down over the last 5 days. If we measure the stock’s price variations over the week and the month, we find that the volatility rates stand at 6.82% over the week and 4.98% over the month.
Geron Corporation (GERN) has around 69 employees, a market worth around $1.05B and $1.50M in sales. Distance from 52-week low is 162.38% and -30.99% from its 52-week high. The company has generated returns on investments over the last 12 months (-64.70%).
Geron Corporation (GERN) Analyst Forecasts
Geron Corporation is expected to release its quarterly report on 05/08/2023.The EPS is expected to shrink by -27.20% this year
Geron Corporation (GERN) Top Institutional Holders
The shares outstanding are 405.24M, and float is at 380.57M with Short Float at 6.46%.
Geron Corporation (GERN) Insider Activity
A total of 15 insider transactions have happened at Geron Corporation (GERN) in the last six months, with sales accounting for 6 and purchases happening 9 times. The most recent transaction is an insider sale by SCARLETT JOHN A, the company’s Chairman, President and CEO. SEC filings show that SCARLETT JOHN A sold 446,668 shares of the company’s common stock on Feb 10 at a price of $3.00 per share for a total of $1.34 million. Following the sale, the insider now owns 0.0 shares.
Geron Corporation disclosed in a document filed with the SEC on Feb 09 that SCARLETT JOHN A (Chairman, President and CEO) sold a total of 446,666 shares of the company’s common stock. The trade occurred on Feb 09 and was made at $3.03 per share for $1.35 million. Following the transaction, the insider now directly holds 0.0 shares of the GERN stock.
Still, SEC filings show that on Feb 09, GRETHLEIN ANDREW J (EVP, Chief Operating Officer) disposed off 384,719 shares at an average price of $3.03 for $1.17 million. The insider now directly holds 0 shares of Geron Corporation (GERN).
Geron Corporation (GERN): Who are the competitors?
The company’s main competitors (and peers) include CTI BioPharma Corp. (CTIC) that is trading -1.34% down over the past 12 months and Bio-Techne Corporation (TECH) that is -27.52% lower over the same period. Incyte Corporation (INCY) is 0.90% up on the 1-year trading charts.
